It has been shown that MFN2 and OPA1 are downregulated in COPD, whereas increasing MFN2 and OPA1 expression can somehow attenuate oxidative stress and cellular senescence (Li et al., 2023; Maremanda et al., 2021). Here, OPA1 is linked to chronic obstructive pulmonary disease.